Literature DB >> 15710940

The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.

Richelle J Cooper1, David L Schriger.   

Abstract

BACKGROUND: The primary goal of pharmaceutical advertisements is to convince physicians to prescribe the manufacturer's product. We sought to determine what materials are cited in support of claims in pharmaceutical ads and medical research articles, and whether health care professionals seeking to verify the claims could obtain these references.
METHODS: We reviewed 438 unique ads from the 1999 issues of 10 American medical journals, and a random sample of 400 references in medical research articles selected from the same journals. We classified references as journal article, data on file, meeting abstract or presentation, book or monograph, marketing report, prescribing information, government document or Internet site. We attempted to confirm or obtain each reference through library and Internet searches or by direct request from the manufacturer. The main outcome we sought to determine was the availability of the reference to a clinician. We also ascertained the source of funding for original research cited in the ads and the research articles.
RESULTS: In the 438 ads with medical claims, 126 contained no references and 312 contained 721 unique references. Of these ad references, 55% (396/721) cited journal articles and 19% (135/721) cited data on file. In contrast, in the sample of research article references, 88% (351/400) cited journal articles and 8% (33/400) cited books. Overall, 84% of the citations from the ads were available: 98% of journal articles, 86% of books, 71% of meeting abstracts or presentations and 20% of data-on-file references. In all, 99% of the sample of research article references were available. We determined that 58% of the original research cited in the pharmaceutical ads was sponsored by or had an author affiliated with the product's manufacturer, as compared with 8% of the articles cited in the research articles.
INTERPRETATION: Many pharmaceutical ads contain no references for medical claims. Although references to journal articles were usually obtainable, other published sources were not as easily acquired. The majority of unpublished data-on-file references were not available, and the majority of original research cited to substantiate claims in the pharmaceutical ads was funded by or had authors affiliated with the product's manufacturer.

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Substances:

Year:  2005        PMID: 15710940      PMCID: PMC548410          DOI: 10.1503/cmaj.1031940

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  24 in total

1.  The quantity and quality of scientific graphs in pharmaceutical advertisements.

Authors:  Richelle J Cooper; David L Schriger; Roger C Wallace; Vladislav J Mikulich; Michael S Wilkes
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

Review 2.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors:  Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal:  BMJ       Date:  2003-05-31

3.  Relationship between conflicts of interest and research results.

Authors:  Lee S Friedman; Elihu D Richter
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

Review 4.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

5.  Accuracy of pharmaceutical advertisements in medical journals.

Authors:  Pilar Villanueva; Salvador Peiró; Julián Librero; Inmaculada Pereiró
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

6.  Open access to industry's clinically relevant data.

Authors:  Andrew Herxheimer
Journal:  BMJ       Date:  2004-07-10

7.  Addressing the problem of misleading advertising.

Authors:  D A Kessler
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

8.  Pharmaceutical advertisements in leading medical journals: experts' assessments.

Authors:  M S Wilkes; B H Doblin; M F Shapiro
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

9.  Source of funding and outcome of clinical trials.

Authors:  R A Davidson
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

10.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

View more
  14 in total

1.  Explanatory model of prescribing behavior in prescription of statins in family practice.

Authors:  Ksenija Tusek-Bunc; Janko Kersnik; Marija Petek-Ster; Davorina Petek; Zalika Klemenc-Ketis
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

2.  Standards for pharmaceutical advertising in Canada.

Authors:  Ray Chepesiuk
Journal:  CMAJ       Date:  2005-08-02       Impact factor: 8.262

3.  Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.

Authors:  Fernando Fernandez-Llimos; Isabel Vazquez Gomez
Journal:  Pharm World Sci       Date:  2007-04-27

4.  Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.

Authors:  Noordin Othman; Agnes I Vitry; Elizabeth E Roughead
Journal:  BMC Public Health       Date:  2010-05-29       Impact factor: 3.295

5.  Evaluation of rationality of promotional drug literature using World Health Organization guidelines.

Authors:  Smita N Mali; Sujata Dudhgaonkar; N P Bachewar
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

6.  A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?

Authors:  Roberto Cardarelli; John C Licciardone; Lockwood G Taylor
Journal:  BMC Fam Pract       Date:  2006-03-03       Impact factor: 2.497

7.  Advertising in medical journals: should current practices change?

Authors:  Adriane Fugh-Berman; Karen Alladin; Jarva Chow
Journal:  PLoS Med       Date:  2006-05       Impact factor: 11.069

8.  Differences in the volume of pharmaceutical advertisements between print general medical journals.

Authors:  Jennifer Gettings; Braden O'Neill; Dave A Chokshi; James A Colbert; Peter Gill; Gerald Lebovic; Joel Lexchin; Navindra Persaud
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 9.  Quality of pharmaceutical advertisements in medical journals: a systematic review.

Authors:  Noordin Othman; Agnes Vitry; Elizabeth E Roughead
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

10.  A Critical Analysis of Claims and Their Authenticity in Indian Drug Promotional Advertisements.

Authors:  Gurpreet Kaur Randhawa; Navyug Raj Singh; Jaswant Rai; Gobindnoor Kaur; Resham Kashyap
Journal:  Adv Med       Date:  2015-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.